NZCity NewsLinks -

All Links

22 Nov 2024

Search

Healthcare and animal products company EBOS posts strong profits
The chief executive out put the performance down growth in the community pharmacy and institutional healthcare divisions.

EBOS profits up thanks to boost in healthcare spending
Pharmaceutical supplier and animal products company EBOS has posted a solid lift in half-year profit.

Potential Ebos takeover called off after failed talks
Ebos has reportedly been in discussions with Australian pet care company Greencross over a potential deal, but discussions have concluded.

Chemist Warehouse to drop Ebos as supplier
Pharmaceutical supplier Ebos is to lose a major customer, potentially knocking a $2.1 billion hole in its earnings.

Healthcare company EBOS posts record half-year profit
Chief executive John Cullity said it was driven by new acquisitions and growth in its healthcare division.

EBOS earnings rocket up 21pc to new record, lifts dividend
Medical supplies and animal healthcare company EBOS Group said strong first half growth was replicated in the second, driving underlying net profit up 21.3 per cent to a record A$228.2 million in the June year, its 100th year of operation.The...

ACCC Announcement Regarding LifeHealthcare Acquisition
EBOS Group Limited (EBOS) notes the announcement by the Australian Competition and Consumer Commission (ACCC) today that it will not oppose the proposed acquisition of LifeHealthcare announced on 9 December 2021

Health and animal care products company EBOS posts another record half year profit
Revenue for the community pharmacy for the six months ending December was A$3.15 billion (NZ$3.4b)

EBOS raises first half profit by 15.8% to record $1118m
Dual-listed EBOS Group said strong revenue growth in its key healthcare and animal care businesses drove its underlying net profit up by 15.8 per cent to a record A$109.3 million ($118m) in the six months to December.The diversified...

Ebos Group Limited (NZX: EBO) Retail Offer Oversubscribed
EBOS is pleased to announce that its non-underwritten NZ$105 million (A$100 million) retail offer (Retail Offer) in connection with the agreement to acquire LifeHealthcare has closed oversubscribed

EBOS announces appointment of new Chief Financial Officer
EBOS Group Limited (“EBOS”) is pleased to announce the appointment of Alistair Gray to the role of Chief Financial Officer (“CFO”) with effect from 30 September 2024

EBOS increases its shareholding in Transmedic to 90%
EBOS Group Limited (EBOS) is pleased to announce that it has (via one of its wholly owned subsidiaries) increased its shareholding in Transmedic Pte Ltd (Transmedic) from 51% to 90%

EBOS annual revenue tops A$10 billion for first time
Underlying profit in the company's healthcare business increased by a third, and grew 24 percent in its animal care business.

Julie Tay appointed as independent director
EBOS Group Limited (EBOS) is pleased to announce the appointment of Julie Tay as an independent director, effective 15 May 2023

EBOS annual revenue tops $11 billion for first time
Healthcare and animal care products company EBOS has posted double-digit profit growth.

EBOS - Advance Notice - Full Year Results
EBOS Group Limited will announce its full year financial results for the year ended 30 June 2022 on Wednesday, 24 August 2022

EBOS advises that TerryWhite Chemmart network reaches 500 stores
EBOS Group Limited (“EBOS”) is pleased to advise that TerryWhite Chemmart (“TWC”) has celebrated the opening of its 500th network pharmacy. This milestone demonstrates the strength and momentum of the TWC franchise

Ebos Group Limited (NZX: EBO) Half Year Results
EBOS today announced another record result for the first half of the 2022 financial year, including double-digit underlying earnings growth.The Directors declared an interim dividend of NZ 47.0 cents per share, an increase of 10.6% on the prior period